Trial record 1 of 1 for:    NCT01305109
Previous Study | Return to List | Next Study

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E (ROTAVAC)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Ministry of Science and Technology, India
PATH
Information provided by (Responsible Party):
Bharat Biotech International Limited
ClinicalTrials.gov Identifier:
NCT01305109
First received: February 18, 2011
Last updated: June 9, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)